This trial is unknown!
Search for a recruiting clinical trial for your condition
You can access this
clinical trial
if you have
Invasive Breast Cancer
and you are a woman who is
over 18
years old
Phase
4
The primary goal of this phase is to monitor the long-term effects.
The treatment is already on the market.
Show me locations

The purpose

This study examines the additional benefits of magnetic resonance imaging (MRI) with Gadovist in early breast cancer with poor prognostic features.

Provided treatments

  • Radiation: MRI
Tris trial is registered with FDA with number: NCT01597999. The sponsor of the trial is Mahidol University and it is looking for 60 volunteers for the current phase.
Official trial title:
Accuracy of Magnetic Resonance Imaging (MRI) in Predicting Aggressiveness of Early Breast Cancer According to Molecular Subtypes Identified by ER PR and HER-2 Status